People with SM may face higher risk of skin cancer, study finds
People with mastocytosis may have an elevated risk of melanoma and basal cell carcinoma compared to the general population.
News
-
-
Review explores how genetic advances are reshaping SM diagnosis and treatment
A new review underscores how genetic research is transforming the diagnosis and management of systemic mastocytosis.
-
Case report: Patient diagnosed with both SM and POTS
A rare presentation of systemic mastocytosis (SM) alongside postural orthostatic tachycardia syndrome (POTS) was recently reported.
-
Study highlights the diagnostic challenges of SM-AMN
A new study explores the diagnostic challenges posed by SM with an associated myeloid neoplasm (SM-AMN), an advanced form of SM.
-
Research suggests midostaurin is still effective at lower doses in advanced SM
Midostaurin is safe and effective in treating advanced systemic mastocytosis.
-
Rare case of aggressive systemic mastocytosis identified in newborn
A new case study from New Zealand sheds light on diagnostic and treatment challenges for aggressive systemic mastocytosis in newborns
-
New test may improve detection of KIT mutations
Flow-SuperRCA is a new, ultra-sensitive test to detect the D816V KIT mutation in patients with SM and other mast cell conditions.
-
Case report: SM mistaken for swallowing disorder
A woman with difficulty swallowing and weight loss was initially thought to have a gastrointestinal condition, but was later diagnosed with SM.
-
Rare SM variant linked to new genetic mutations
Well-differentiated systemic mastocytosis (WDSM), a rare SM variant, was recently associated with previously unknown genetic mutations.
-
Drug reactions in SM may be less common than previously thought
Drug-induced reactions such as anaphylaxis are possible in patients with SM, but recent data suggests that the risk is relatively low.
Learn more about SM
Sign up for the latest news, perspectives, and information about SM.
